黑激素作为败血症辅助疗法的有效性:随机对照试验的元分析
Zhuangzhuang Sun1, Cheng Yu1, Zhaopeng Zhang1
1Changchun University of Chinese Medicine, Changchun 130117, China.
Complementary therapies in medicine
|February 23, 2025
概括
作为辅助疗法,黑素显著降低了败血症患者的死亡率和C反应性蛋白 (CRP) 水平. 需要进一步的高质量研究来证实这些有前途的研究结果,以治疗败血症.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 败血症是一种危及生命的疾病,其特点是宿主对感染的反应失调.
- 炎症反应和高死亡率在败血症管理中构成重大挑战.
- 黑激素是一种具有抗氧化和抗炎性能的激素,目前正在研究其在败血症中的治疗潜力.
研究的目的:
- 系统地评估黑激素作为败血症辅助疗法的疗效.
- 为了确定黑激素是否可以降低败血症患者的死亡率.
- 评估黑激素对败血症炎症标志物的影响.
主要方法:
- 对随机对照试验 (RCT) 进行了全面的元分析.
- 在包括PubMed,Web of Science,Cochrane Library和Embase在内的主要数据库中进行了搜索.
- 系统评估了偏见风险,异质性,出版偏见和证据质量 (GRADE).
主要成果:
- 七个带有421名败血症患者的RCT被纳入了分析.
- 黑素辅助治疗显著降低了死亡率 (OR = 0.42,P = 0.005).
- 黑素显著降低了C反应蛋白 (CRP) 水平,表明抗炎作用 (SMD = -4.00,P = 0.001).
结论:
- 作为辅助疗法,黑激素在降低与败血症相关的死亡率方面显示出显著的益处.
- 黑色素有效降低了毒症患者的炎症标志物CRP水平.
- 虽然有希望,但由于研究数量和质量有限,这些发现需要通过高质量的临床试验进一步验证.
相关概念视频
01:19Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143